Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.

Muir, Andrew J; Poordad, Fred F; McHutchison, John G; Shiffman, Mitchell L; Berg, Thomas; Ferenci, Peter; Heathcote, E Jenny; Pawlotsky, Jean-Michel; Zeuzem, Stefan; Reesink, Henk W; Dusheiko, Geoffrey; Martin, Emily C; George, Shelley; Kauffman, Robert S; Adda, Nathalie

Muir, Andrew J; Poordad, Fred F; McHutchison, John G; Shiffman, Mitchell L; Berg, Thomas; Ferenci, Peter; Heathcote, E Jenny; Pawlotsky, Jean-Michel; Zeuzem, Stefan; Reesink, Henk W; Dusheiko, Geoffrey; Martin, Emily C; George, Shelley; Kauffman, Robert S; Adda, Nathalie.

Affiliation

Muir AJ; Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC 27715, USA. muir0002@mc.duke.edu.

Hepatology ; 54(5): 1538-46, 2011 Nov.

Article in En | MEDLINE | ID: mdl-22045671

Subject(s)

Hepatitis C, Chronic/drug therapy; Interferon-alpha/administration & dosage; Oligopeptides/administration & dosage; Polyethylene Glycols/administration & dosage; Ribavirin/administration & dosage; Adult; Antiviral Agents/administration & dosage; Antiviral Agents/adverse effects; Drug Therapy, Combination/methods; Female; Humans; Interferon-alpha/adverse effects; Male; Middle Aged; Oligopeptides/adverse effects; Polyethylene Glycols/adverse effects; Recombinant Proteins/administration & dosage; Recombinant Proteins/adverse effects; Recurrence; Retreatment/methods; Ribavirin/adverse effects; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Polyethylene Glycols / Ribavirin / Interferon-alpha / Hepatitis C, Chronic Type of study: Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Hepatology Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google